http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2360682-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ea47a4d0d0067db3ec642e553905144 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9715ee42ca04792255166d73b4f79385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a49cc756dd5fcac2b9ace52f42c7e1 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 |
filingDate | 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646cca1b32347c88489c3883cc02d398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cf5358fcc39562c383d81fecee4ae07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd92ae3cdbd3ac252a9a7e5c5a6a846d |
publicationDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2360682-C1 |
titleOfInvention | Therapy of bone metastases in breast cancer |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to oncology, and can be used in therapy of breast cancer with bone metastasis. Substance of the invention consists in puncture with a needle between III and IV lumbar vertebras in subarachnoid spinal marrow space. Cerebrospinal fluid in amount 2 ml is poured in a sterile bottle and added with Epitalamine 10 mg. The bottle is incubated in a thermostat at temperature 37°C within 20 minutes. Then the prepared mixed liquor and Epitalamine are introduced back into subarachnoid space that is combined with introduction of hydrocortisone 125 mg. The therapeutic course includes 4 lumbal punctures with introduction of preparations once a week. n EFFECT: application of the invention provides regress of bone metastases, reduced toxic collateral reactions of hormonotherapy, immune correction ensured by combined endoliquor introduction of said agents. n 2 ex |
priorityDate | 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.